ArticleClinical ophthalmology (Auckland, N.Z.)2025

Additional Effects of Faricimab in Aflibercept Low-Responders: Retinal Morphology and Function in Eyes with Neovascular Age Related Macular Degeneration Following a Switch Between Two Anti-VEGF Agents.

Jan Rothbächer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.